Clinic News

Latest in Cardiology

AI-Enabled Clinician: Best Practices of Wearables in Cardiovascular Care
In this episode, Drs. Ami Bhatt, Rupal Oâ€™Quinn, and Leon Ptaszek delve into the role of consumer wearables in cardiovascular care.
ACC Community Health Fairs Offer Framework For Closing Gaps in Care
A Viewpoint published in JACC: Advances makes the case that addressing persistent inequities in cardiovascular health will require scalable, community-centered approaches that bring care, education, and preventive services directly into the communities where people live.
Leadership Gap in Structural Heart Disease Trials Persists
Women remain underrepresented in authorship and leadership roles of clinical trials of structural heart disease (SHD), and targeted efforts and policies to diversify trial leadership may help address the downstream inequities in the generation of cardiovascular evidence, according to a systematic review and meta-analysis published Aug. 12 in JACC: Advances.
COMBINE-AF: Extracranial Bleeding Common With OAC in AFib Treatment
Clinically relevant extracranial bleeding affected approximately one in four patients receiving oral anticoagulation (OAC) for atrial fibrillation (AFib) over two years, potentially providing a more comprehensive measure of bleeding burden than major bleeding alone, according to a recent COMBINE-AF analysis published in Circulation.
Long-Term ASCVD Risk Drives Expanded Statin Eligibility By 2026 Dyslipidemia Guideline
Nearly 25 million more adults in the U.S. are eligible for statin therapy, based on recommendations in the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline, compared with the previous guideline, according to original research published Aug. 12 in JACC.
CMS Proposes Updates to Ambulatory Specialty Model For HF
The Centers for Medicare and Medicaid Services (CMS) has proposed several changes and clarifications to the Ambulatory Specialty Model (ASM) for heart failure (HF) in the 2027 Medicare Physician Fee Schedule proposed rule.
Eagle's Eye View: Lifestyle Intervention Benefits Health Status in ANOCA Patients
In this weekâ€™s View, Dr. Eagle looks at the wide variation in antithrombotic regimens after valve-in-valve transcatheter aortic valve replacement (TAVR). Next, he examines PARTNER-3, a 7-year study on TAVR versus surgical aortic valve replacement (SAVR) outcomes in low-risk patients.
MERCURI-2: Dapagliflozin Before Cardiac Surgery Lowers Postoperative AKI Risk
Starting dapagliflozin one day before elective cardiac surgery reduced the incidence of postoperative acute kidney injury (AKI) during the first seven days after surgery, according to results from the double-blind, placebo-controlled MERCURI-2 trial published July 30 in JAMA.
FFR in Focus: New Insights on Angiography-Derived Assessment and FFR-NHPR Discordance
Two studies recently published in JACC: Cardiovascular Interventions provide fresh insights into coronary physiology, suggesting that angiography-derived fractional flow reserve (FFR) may be a practical alternative to wire-based FFR, while highlighting the prognostic significance of definite discordance between FFR and nonhyperemic pressure ratios (NHPR).
Central Adiposity as Predictor of CV Outcomes | JACC Special Issue on Obesity
Waist circumference (WC) and waist-to-hip ratio (WHR) provide additional diagnostic and prognostic value compared with conventional BMI categories alone, which may misclassify cardiovascular disease risk, according to results from the Cross-Cohort Collaboration (CCC) Obesity Working Group published Aug. 11 in JACC.